Goldman Sachs Group Inc Vertex Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $555 Billion
  • Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,400,960 shares of VRTX stock, worth $638 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,400,960
Previous 1,484,934 5.66%
Holding current value
$638 Million
Previous $604 Million 3.08%
% of portfolio
0.11%
Previous 0.11%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$407.69 - $446.08 $34.2 Million - $37.5 Million
-83,974 Reduced 5.66%
1,400,960 $586 Million
Q4 2023

Feb 13, 2024
SELL
$343.0 - $410.68 $72.2 Million - $86.4 Million
-210,391 Reduced 12.41%
1,484,934 $604 Million
Q3 2023

May 14, 2024
BUY
$338.18 - $362.46 $71.2 Million - $76.3 Million
210,391 Added 14.17%
1,695,325 $590 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $40.8 Million - $43.7 Million
-120,547 Reduced 6.64%
1,695,325 $590 Million
Q2 2023

May 14, 2024
BUY
$314.42 - $351.91 $32.7 Million - $36.6 Million
104,141 Added 6.08%
1,815,872 $639 Million
Q2 2023

Aug 14, 2023
BUY
$314.42 - $351.91 $32.7 Million - $36.6 Million
104,141 Added 6.08%
1,815,872 $639 Million
Q1 2023

May 14, 2024
BUY
$283.23 - $323.1 $11.1 Million - $12.7 Million
39,358 Added 2.35%
1,711,731 $539 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $11.1 Million - $12.7 Million
39,358 Added 2.35%
1,711,731 $539 Million
Q4 2022

May 14, 2024
SELL
$285.76 - $321.48 $13.8 Million - $15.6 Million
-48,374 Reduced 2.81%
1,672,373 $483 Million
Q4 2022

Feb 13, 2023
SELL
$285.76 - $321.48 $13.8 Million - $15.6 Million
-48,374 Reduced 2.81%
1,672,373 $483 Million
Q3 2022

May 14, 2024
BUY
$273.83 - $305.53 $184 Million - $206 Million
673,107 Added 64.25%
1,720,747 $498 Million
Q3 2022

Nov 10, 2022
BUY
$273.83 - $305.53 $184 Million - $206 Million
673,107 Added 64.25%
1,720,747 $498 Million
Q2 2022

May 14, 2024
SELL
$234.96 - $292.55 $103 Million - $128 Million
-437,294 Reduced 29.45%
1,047,640 $295 Million
Q2 2022

Aug 15, 2022
SELL
$234.96 - $292.55 $46.1 Million - $57.4 Million
-196,067 Reduced 15.76%
1,047,640 $295 Million
Q1 2022

May 16, 2022
BUY
$221.42 - $260.97 $12.5 Million - $14.7 Million
56,330 Added 4.74%
1,243,707 $325 Million
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $36.5 Million - $46.1 Million
-206,385 Reduced 14.81%
1,187,377 $261 Million
Q3 2021

Nov 10, 2021
BUY
$181.39 - $202.99 $253 Million - $283 Million
1,393,762 New
1,393,762 $253 Million

Others Institutions Holding VRTX

# of Institutions
1,623
Shares Held
222M
Call Options Held
1.35M
Put Options Held
1.49M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $117B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email